HOME >> BIOLOGY >> NEWS
Grant renews funding of research toward cloning primates

PITTSBURGH, Aug. 29 The National Institutes of Health (NIH) has awarded nearly $6.4 million to the Pittsburgh Development Center, which is affiliated with the University of Pittsburgh, to fund investigation aimed at overcoming obstacles to cloning nonhuman primates. Cloning primates is vital to generate better research models for human disease so that studies obtain more accurate results with fewer animals. It also could lead to a greater understanding of the molecular biology of embryonic stem cells, which have the promise to treat disorders such as diabetes and Parkinson's disease as well as damaged hearts and other organs.

The five-year grant award renews funding originally conferred in 1998 to principal investigator Gerald Schatten, Ph.D., director of the Pittsburgh Development Center (PDC) of the Magee-Womens Research Institute, and professor of obstetrics, gynecology and reproductive sciences and cell biology and physiology at the University of Pittsburgh School of Medicine. Co-investigators include Calvin Simerly, Ph.D.; Christopher Navara, Ph.D.; and Laura Hewitson, Ph.D., all of the PDC.

"Valuable discoveries have been made and continue to be made using mice, rats and other genetically modified rodent species as models for human disease, yet many serious disorders often cannot be appropriately studied in these lower animals," said Dr. Schatten, who also is vice chair for research development and deputy director for biotechnology development at the Magee-Womens Research Institute. "Cloned and transgenic nonhuman primates could accelerate the safe and effective implementation of innovative treatments, including stem cell and gene therapies, as well as the understanding of the molecular basis of normal human development."

Scientists at the Pittsburgh Development Center have ambitious goals for the five-year grant period, including overcoming fundamental molecular obstacles to cloning nonhuman primates first reported by the group in
'"/>

Contact: Michele Baum
412-647-3555
University of Pittsburgh Medical Center
29-Aug-2003


Page: 1 2 3

Related biology news :

1. Grant advances biochemical engineering laboratory
2. GlaxoSmithKline Drug Discovery and Development Research Grant Program 2004
3. Grant from GE Foundation to University of Houston to strengthen math, tech pipeline
4. McGill Centre for Intellectual Property Policy receives $3 million SSHRC Grant
5. Grant promotes marine ornamental fish aquaculture
6. Grant of powerful computer to Rutgers-Newark will increase understanding of brain activity
7. Lipids get the spotlight in new NIGMS Glue Grant
8. Grant funds research to develop tissue-engineered solutions for heart disease
9. Grant strengthens research arm of Penn State Hershey Medical Centers ALS Clinic
10. Sea Grant News & Notes for March 26, 2003
11. Grant funds research to develop microbicide barrier to HIV

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/5/2019)... , ... April 04, 2019 , ... ... with integrated linear encoders providing 0.05 microns and 0.005 microns resolution, respectively. The ... and drive variations are available, from fast DC-servo motors with linear encoders and ...
(Date:4/4/2019)... ... April 02, 2019 , ... The live session ... into the connectivity between product risk management (ISO 14971) and the clinical risk ... process. , With increasing global regulation and reimbursement challenges faced by medical device ...
(Date:4/1/2019)... (PRWEB) , ... April 01, 2019 , ... ... and System for Characterizing Skin Related Conditions” by the US Patent and Trademark ... The patent is an invention by uBiome collaborators Dr. Zachary Apte, Dr. ...
Breaking Biology News(10 mins):
(Date:4/9/2019)... ... April 09, 2019 , ... Sonny Bar Lisa, or Sonny ... for approximately two months. After a series of diagnostics, an MRI was performed ... owner, Alison, researched the injury and found that VetStem Regenerative Cell Therapy ...
(Date:4/8/2019)... ... April 08, 2019 , ... US Capital Global ... $15 million preferred equity investment in the privately held pharmaceutical company, S1 Biopharma (“S1”). ... Lorexys, is targeted at female hypoactive sexual dysfunction disorder and is ready to begin ...
(Date:4/4/2019)... (PRWEB) , ... April 03, 2019 , ... ... together through intimate off-the-record collaboration and dialogue, today announces its Boston CEO conference ... offers insights into the industry’s challenges and opportunities with high-level panels and discussions ...
(Date:3/27/2019)... ... March 27, 2019 , ... In honor of National Nutrition Month, ... importance of healthy meals and good nutrition. This month, Chef Jodi Abel appeared ... chef. , The first segment addressed the nutritional value of USDA’s MyPlate, ...
Breaking Biology Technology:
Cached News: